Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

777.77 +11.09 (+1.45%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,879,450
Open 768.90
Bid (Size) 774.00 (3)
Ask (Size) 777.50 (1)
Prev. Close 766.68
Today's Range 762.11 - 779.09
52wk Range 419.80 - 800.78
Shares Outstanding N/A
Dividend Yield 0.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hedge Fund Legend Druckenmiller Shares His Top Secrets For 30% Returns
Legendary hedge fund manager Stanley Druckenmiller made right bets at the right time. He came to fame for earning Soros $10B overnight. Successful hedge fund, Duquesne Capital, boasts $10B fortune. 
Via Benzinga
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy. 
Via InvestorPlace

Performance

YTD
+31.34%
+31.34%
1 Month
+0.06%
+0.06%
3 Month
+10.32%
+10.32%
6 Month
+29.64%
+29.64%
1 Year
+79.74%
+79.74%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Via Benzinga
Exposures Product Safety
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Via NewMediaWire
Exposures COVID-19
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,200 Today
Via Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Via TheNewswire.com
Exposures COVID-19
Why Eli Lilly Stock Jumped by 4% Today
Via The Motley Fool
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Via MarketBeat
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
2 Top Stocks That Could Make You Richer in 2024
Via The Motley Fool
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
Via The Motley Fool
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Via The Motley Fool
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Via The Motley Fool
Why Amgen Stock Zoomed Nearly 12% Higher Today
Via The Motley Fool
3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
Via Benzinga
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Via The Motley Fool
Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.